Skip to content
Case report Open access

Progressive Ataxia and Cognitive Impairment Associated With SEZ6L2: Serum Neurofilament Light Chain as a Biomarker of Disease Activity

Nov 2026 · Brain and Behavior · Vol 16 · 0 citations · 4 references
Medicine

TL;DR

AE can mimic neurodegenerative processes, and SEZ6L2 antibody testing should be considered in patients with progressive ataxia and limbic involvement, even when no additional clues point towards an autoimmune etiology.

Abstract

ABSTRACT Introduction Autoimmune encephalitis (AE) associated with SEZ6L2 antibodies is a rare neurological disorder characterized by subacute onset of cerebellar ataxia, cognitive dysfunction, and extrapyramidal features. Few cases have been reported, and data on long‐term course and treatment response remain limited. Case Presentation A 64‐year‐old woman developed progressive cerebellar ataxia, cognitive decline, and psychiatric symptoms starting insidiously after SARS‐CoV‐2 pneumonia in September 2022. Magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) analysis almost 1 year after onset were unremarkable. Due to progressive symptoms, she was admitted to our department in December 2024. Examination showed severe truncal and gait ataxia, memory impairment, and prominent frontal‐executive dysfunction. Brain MRI demonstrated bilateral hippocampal T2 hyperintensity with severe medial temporal lobe and cerebellar atrophy. Neuronal antibody testing with a tissue‐based assay (TBA) optimized for surface antigens showed strong neuropilar hippocampal and cerebellar staining in serum and CSF. A specific live cell‐based assay (CBA) confirmed that the reactivity could be attributed to SEZ6L2 antibodies. Plasmapheresis and high‐dose corticosteroids resulted in stabilization of gait impairment and mild cognitive improvement. Longitudinal plasma neurofilament light chain (NFL) monitoring showed initially high levels (85.12 pg/mL), followed by a drastic reduction some months after immunotherapy. Conclusions AE can mimic neurodegenerative processes, and SEZ6L2 antibody testing should be considered in patients with progressive ataxia and limbic involvement, even when no additional clues point towards an autoimmune etiology. Notably, the condition manifested a partial response to immunotherapy, supported by NFL reduction. This suggests that NFL might represent a useful biomarker to monitor disease activity in these conditions.

Read PDF

Similar papers

Open access Nov 2026

Case Report: Cerebellar ataxia with serum anti-GluK2 positivity and a multiple system atrophy–like phenotype: a longitudinal diagnostic dilemma

Anti-GluK2 antibody–associated neurologic disease is a rare neuronal antibody–associated syndrome that frequently involves the cerebellum, but its long-term clinical evolution remains poorly defined. We report a 53-year-old woman who initially presented predominantly with cerebellar ataxia. Brain MRI showed cerebellar...

Liu-Chang He, L. Cong, Zun-Jing Liu et al. · 0 citations
Case report Open access Sep 2026

A previously unreported ELOVL4 frameshift variant in a patient with early severe cognitive decline, parkinsonism, and cerebellar ataxia

This case describes a previously unreported ELOVL4 frameshift variant in a patient with cerebellar ataxia, parkinsonism, severe cognitive impairment, and autonomic dysfunction, and genetic testing may facilitate differentiation of hereditary ataxia from atypical degenerative syndromes.

Jing-Tong Zhou, Xia Wen, Zhi-Jun Lin · 0 citations
Open access Oct 2026

Atypical slowly progressive Creutzfeldt–Jakob disease presenting as mild cognitive impairment with initially normal cerebrospinal fluid and early cortical ribboning on MRI

Case Presentation: A 60-year-old man with a high educational level, including postgraduate training, presented with insidious cognitive complaints and subacute progression. Initial neurological evaluation revealed mild cognitive impairment with deficits in visuospatial and executive functions and delayed recall. Given...

Louise Albeny Gonçalves Paris, Eduarda Heringer Bernis, Rafaela Gatti Lopes et al. · 0 citations
Open access Oct 2026

Post-COVID immune-mediated encephalitis with severe cerebellar syndrome: case report

Case Presentation: A patient developed progressive gait imbalance and difficulty with fine motor coordination, evolving over approximately eight weeks to an inability to walk. On neurological examination, the patient was alert but presented attention deficits, memory and language impairment, scanning speech, severe axi...

B. Godoi, Rodrigo Seixas Dourado, Barbara Silveira B. De Oliveira et al. · 0 citations
Open access Oct 2026

Rapidly progressive dementia with negative CSF 14-3-3 protein and typical MRI findings: a probable case of sporadic doença de Creutzfeldt-Jakob

Case Presentation: A 67-year-old previously healthy female was referred for neurological evaluation due to rapidly progressive dementia. According to family members, symptoms began approximately seven months earlier with insidious behavioral changes, progressively evolving to hypervigilance, bradyphrenia, and motor inc...

Aléxia Zattar, Yasmin Ramalho Mandarino, Laura Monteiro et al. · 0 citations
Open access Oct 2026

Late-onset progressive ataxia associated with biallelic expansion of the RFC1 gene: genetically confirmed CANVAS syndrome — case report

Case Presentation: A 79-year-old female patient with a history of hypertension presented with chronic cough and a three-year history of progressive imbalance associated with orthostatic dizziness. The condition progressed to marked postural instability and recurrent falls during the past year, resulting in a right fore...

Gabriela Cardoso Traven, M. Carneiro, P. Feitoza · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.